Lenalidomide 10 mg | LENALIMIDE 10
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition lenalidomide 10 mg
Rs 622.78
MRP Rs 889.69
(30% OFF)
Includes all taxes
Package SIZE
( For 10 Tablet )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
Lenalidomide is an oral anti-cancer immunomodulator prescribed for multiple myeloma, mantle cell lymphoma, and specific MDS types. It is not a traditional cytotoxic chemotherapy agent in the classic sense — instead, it belongs to a class of targeted, immune-modulating anti-cancer medicines that are frequently used in combination with steroids, monoclonal antibodies, or other cancer drugs. Lenalidomide 10mg capsules are typically prescribed as part of ongoing maintenance therapy or dose-adjustment protocols, following an initial higher starting dose in many myeloma regimens.
Clinical Indications
| Condition | Typical Use Case |
|---|---|
| Multiple Myeloma (MM) | Newly diagnosed MM (in combination with dexamethasone), and maintenance therapy after autologous stem cell transplant (ASCT) |
| Myelodysplastic Syndromes (MDS) | Transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q (del(5q)) cytogenetic abnormality |
| Mantle Cell Lymphoma (MCL) | Relapsed or refractory MCL after prior therapy |
| Follicular Lymphoma / Marginal Zone Lymphoma | Previously treated, in combination with rituximab (R² regimen) |
Key Benefits of Lenalidomide 10mg
- Dual mechanism of action — Lenalidomide binds to a protein called cereblon (CRBN), part of an E3 ubiquitin ligase complex. This leads to the breakdown of two transcription factors, Ikaros and Aiolos, inside cancer cells, which slows tumor growth directly while also switching on T-cells and natural killer (NK) cells to attack the cancer.
- Anti-angiogenic effect — It reduces the formation of new blood vessels that tumors rely on for growth and spread.
- Convenient oral dosing — Unlike IV chemotherapy, lenalidomide is taken as a capsule at home, improving quality of life and reducing hospital visits.
- Established maintenance role — Widely used as long-term maintenance therapy after stem cell transplant in multiple myeloma to help delay disease progression.
- Combination flexibility — Works well alongside dexamethasone, bortezomib, daratumumab, and rituximab in various approved regimens, allowing doctors to tailor treatment.
- Transfusion independence in MDS — In eligible del(5q) MDS patients, it can reduce or eliminate the need for regular blood transfusions.
Dosage Guidelines
- Lenalidomide 10mg is generally taken once daily, at approximately the same time every day, with or without food.
- Capsules must be swallowed whole — they should never be opened, broken, or chewed, due to the drug's teratogenic potential.
- Dosing typically follows a cyclical schedule (for example, Days 1–21 of a 28-day cycle, followed by a 7-day rest period), though exact schedules vary by indication and physician protocol.
- Renal (kidney) function determines dose: because lenalidomide is largely cleared through the kidneys, patients with reduced creatinine clearance require dose reduction, and regular kidney function monitoring is essential throughout treatment.
- Duration of therapy varies — some patients continue on maintenance doses for months to years, or until disease progression or unacceptable side effects occur.
- Dose adjustments are also commonly required in response to blood count changes (neutropenia or thrombocytopenia).
Side Effects of Lenalidomide 10mg
Common side effects:
- Neutropenia (low white blood cell count) and increased infection risk
- Thrombocytopenia (low platelets) and easy bruising/bleeding
- Anemia and fatigue
- Diarrhea or constipation
- Muscle cramps and joint pain
- Skin rash and itching (pruritus)
- Peripheral neuropathy (tingling/numbness in hands or feet)
Serious risks requiring immediate medical attention:
- Venous thromboembolism (VTE) — deep vein thrombosis (DVT) and pulmonary embolism (PE); many regimens include blood-thinner prophylaxis (e.g., low-dose aspirin or anticoagulants) alongside lenalidomide for this reason
- Severe birth defects or fetal death if taken during pregnancy — lenalidomide must never be used by pregnant women, and strict pregnancy-prevention measures are mandatory for patients who can become pregnant
- Second primary malignancies — a small increased long-term risk of new cancers has been reported with extended use, particularly in myeloma maintenance settings
- Hepatotoxicity (liver enzyme elevation), in rare cases
- Tumor flare reaction, occasionally seen in lymphoma/CLL patients starting therapy
- Severe allergic reactions (rash, swelling, difficulty breathing)
Substitutes and Related Therapies
| Category | Examples |
|---|---|
| Other IMiDs | Thalidomide, Pomalidomide |
| Combination partners | Dexamethasone, Bortezomib, Daratumumab, Rituximab |
| Alternative MDS therapies | Erythropoiesis-stimulating agents, hypomethylating agents (for non-del(5q) MDS) |
Precautions
- Mandatory pregnancy-prevention program (contraception counselling, pregnancy testing) for all patients who can become pregnant; male patients must also use contraception, as lenalidomide is present in semen.
- Regular complete blood count (CBC) monitoring, especially in the first few cycles.
- Kidney function (creatinine clearance) must be checked before starting and periodically during treatment.
- Blood-clot prevention measures (compression stockings, low-dose aspirin, or anticoagulants) as advised by the physician.
- Avoid alcohol unless cleared by your doctor, and stay well hydrated.
- Inform your doctor of all other medications, including over-the-counter drugs and supplements, to avoid interactions.
- Not to be handled by pregnant women or by anyone other than the patient; capsules should not be shared.
Frequently Asked Questions
1. What cancer is lenalidomide used for?
Lenalidomide is mainly used for multiple myeloma, certain types of myelodysplastic syndromes (MDS) with a del(5q) abnormality, mantle cell lymphoma, and follicular lymphoma.
2. What are the side effects of lenalidomide 10mg?
Common side effects include low blood counts (neutropenia, thrombocytopenia, anemia), fatigue, diarrhea or constipation, muscle cramps, and skin rash. Serious risks include blood clots, birth defects if used in pregnancy, and a small increased risk of second cancers with long-term use.
3. Is lenalidomide taken daily?
Yes, it is usually taken once daily at the same time each day, but typically in a cycled pattern (such as 21 days on and 7 days off) rather than continuously without breaks, depending on the treatment protocol.
4. When should I take lenalidomide 10mg?
It should be taken at approximately the same time every day, with or without food, exactly as prescribed by your doctor. Consistency in timing helps maintain steady drug levels.
5. Can lenalidomide damage kidneys?
Lenalidomide is cleared mainly through the kidneys, so patients with reduced kidney function need a lower dose. While it isn't a classic "nephrotoxic" drug in most patients, kidney function must be monitored regularly during treatment and doses adjusted accordingly.
6. How long is lenalidomide given for?
Duration varies widely by condition — some patients take it for a fixed number of cycles, while others (especially in myeloma maintenance after transplant) continue for months to years, or until the disease progresses or side effects become unmanageable.
7. What not to eat when taking lenalidomide?
There are no major specific foods that must be avoided with lenalidomide, but patients are generally advised to limit alcohol, stay well hydrated, and maintain consistent eating habits alongside their dosing schedule. Always confirm dietary precautions with your treating doctor.
8. Why take lenalidomide at night?
Some doctors recommend taking it at bedtime to help patients sleep through common side effects like fatigue or mild nausea; however, this is a practical scheduling preference rather than a strict medical requirement — follow your doctor's specific instructions on timing.
9. What are the risks of lenalidomide?
Key risks include blood clots (DVT/PE), severe drops in blood counts, birth defects or fetal harm if taken during pregnancy, liver enzyme changes, and a modest long-term risk of secondary cancers.
10. Do you lose your hair with lenalidomide?
Significant hair loss is uncommon with lenalidomide, unlike traditional chemotherapy. Some patients report mild hair thinning, but complete alopecia is rare.
11. Is lenalidomide 10 mg a chemotherapy drug?
Lenalidomide is technically an immunomodulatory agent, not a classic cytotoxic chemotherapy drug — it works by modulating the immune system and cutting off tumor blood supply rather than directly poisoning dividing cells. However, it is used as part of cancer treatment regimens and is often grouped with chemotherapy in general conversation.
12. Can lenalidomide be taken with food?
Yes, it can be taken with or without food, but it should be taken consistently the same way each day as advised by your doctor.
13. Does lenalidomide cause weight gain or weight loss?
Weight changes are not among the most commonly reported effects, though fatigue, appetite changes, and gastrointestinal symptoms may indirectly affect weight in some patients.
14. Is lenalidomide safe during pregnancy?
No. Lenalidomide is strictly contraindicated in pregnancy due to a high risk of severe birth defects or fetal death. Strict contraception and pregnancy-testing protocols are mandatory for patients who can become pregnant.
15. What blood tests are needed while taking lenalidomide?
Regular complete blood counts (CBC) to monitor for neutropenia and thrombocytopenia, along with periodic kidney and liver function tests, are typically required throughout treatment.
16. Can lenalidomide be stopped suddenly?
Lenalidomide should never be stopped or adjusted without your doctor's guidance, as dose changes are usually made gradually based on blood counts and side effects.
17. Is lenalidomide available as a generic in India?
Lenalidomide is available from multiple manufacturers in India under different brand names, all requiring a valid oncologist/hematologist prescription (Schedule H1).
Conclusion
Lenalidomide 10mg plays an important role in the modern treatment of multiple myeloma, certain myelodysplastic syndromes, and select lymphomas, offering the convenience of oral dosing alongside a distinct immune-based mechanism of action. Its benefits — from enabling transfusion independence in del(5q) MDS to supporting long-term maintenance therapy after stem cell transplant — make it a valuable option in an oncologist's toolkit. At the same time, it carries serious risks, including blood clots, low blood counts, and severe teratogenic effects, which is why it is available strictly on prescription and requires close medical supervision, regular blood monitoring, and mandatory pregnancy-prevention measures where applicable. Patients should never start, stop, or adjust their lenalidomide dose without consulting their treating doctor, and any new or worsening symptoms should be reported immediately.